Annual expenses on research and development (R&D) of Nichi-Iko Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Sawai Group's net income FY 2013-2022
- Premium Statistic Sawai Pharmaceutical's total assets FY 2011-2020
- Premium Statistic Sawai's drug sales share in Japan FY 2018, by institution
- Premium Statistic Major drug manufacturers Japan 2017, by number of products
- Premium Statistic Sawai Pharmaceutical's number of employees FY 2013-2022
- Premium Statistic Sawai Pharmaceutical's number of patents FY 2013-2022
- Premium Statistic Nichi-Iko's total assets FY 2013-2022
- Premium Statistic U.S. development phase success rates for drugs with and without biomarkers 2011-2020
- Basic Statistic U.S. venture investments in neurology companies 2006-2023
- Basic Statistic U.S. venture investments in infectious disease companies 2006-2023
About the region
10
- Premium Statistic Sawai Group's R&D expenditure FY 2013-2022
- Premium Statistic Fuji Pharma's R&D costs FY 2013-2022
- Premium Statistic Prescription drug market sales share of LLPs Japan 2008-2019
- Premium Statistic Prescription drug market sales share of original drugs 2008-2019
- Premium Statistic Major pharmaceutical companies in prescription drug sales Japan 2022, by distributor
- Basic Statistic Sawai Group's sales revenue FY 2013-2022
- Premium Statistic Fuji Pharma's total assets FY 2013-2022
- Premium Statistic Generics drug market size Japan 2005-2020
- Premium Statistic Share of prescription drug market Japan 2010-2019 , by category
- Basic Statistic Nichi-Iko's sales revenue FY 2013-2022
Selected statistics
4
Other regions
10
- Basic Statistic Rx drugs by type used widely by older Americans 2017
- Premium Statistic Global pharma companies by Facebook post likes 2012-2013
- Premium Statistic Revenue share of major pharmaceutical companies Thailand 2021
- Premium Statistic Saudi Pharmaceutical Industries and Medical Appliances Corporation revenue 2012-2018
- Basic Statistic Sales value of pharmaceuticals in pharmacies in Sweden 2008-2022
- Premium Statistic Yuhan Chemical's sales revenue 2016-2019
- Premium Statistic Top pharmaceutical companies in Argentina 2014 by revenue
- Premium Statistic Pharmaceutical sales in Mexico 2015-2021
- Premium Statistic Expenditure for self-medication products in Italy 2013-2022
- Basic Statistic producer price index of chemical and pharmaceutical products in Norway 2008-2022
Related statistics
10
- Premium Statistic Nichi-Iko's gross profit FY 2013-2022
- Premium Statistic Nichi-Iko's sales share of generics in Japan FY 2013-2022
- Premium Statistic Volume share of generics in prescription drug market Japan 2005-2022
- Premium Statistic Takeda Pharmaceutical's R&D expenditure FY 2013-2022
- Premium Statistic Pharmaceutical market size Japan 2008-2015
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Premium Statistic Towa Pharmaceutical's profit FY 2012-2017
- Premium Statistic Astellas Pharma's net profit FY 2013-2022
- Premium Statistic Astellas Pharma's total assets FY 2013-2022
- Premium Statistic Astellas Pharma's revenue FY 2022, by region
Further related statistics
10
- Biotech company distribution by geographical location
- MorphoSys' research & development expenditure 2006-2023
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Pfizer's ad spending 2006-2023
- Total assets of UnitedHealth Group 2007-2023
- Net earnings of UnitedHealth Group 2007-2023
- Deaths by motor vehicle-related injuries in the U.S. 1950-2019
- Deaths by prostate cancer in the U.S. 1950-2019
- New cases of mumps in the U.S. 1970-2019
- New cases of shigellosis in the U.S. 1950-2019
Further Content: You might find this interesting as well
Statistics
- Biotech company distribution by geographical location
- MorphoSys' research & development expenditure 2006-2023
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Pfizer's ad spending 2006-2023
- Total assets of UnitedHealth Group 2007-2023
- Net earnings of UnitedHealth Group 2007-2023
- Deaths by motor vehicle-related injuries in the U.S. 1950-2019
- Deaths by prostate cancer in the U.S. 1950-2019
- New cases of mumps in the U.S. 1970-2019
- New cases of shigellosis in the U.S. 1950-2019
Shared Research. (June 6, 2022). Annual expenses on research and development (R&D) of Nichi-Iko Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen) [Graph]. In Statista. Retrieved March 29, 2024, from https://www.statista.com/statistics/800282/nichi-iko-pharmaceutical-research-and-development-expenses/
Shared Research. "Annual expenses on research and development (R&D) of Nichi-Iko Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen)." Chart. June 6, 2022. Statista. Accessed March 29, 2024. https://www.statista.com/statistics/800282/nichi-iko-pharmaceutical-research-and-development-expenses/
Shared Research. (2022). Annual expenses on research and development (R&D) of Nichi-Iko Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen). Statista. Statista Inc.. Accessed: March 29, 2024. https://www.statista.com/statistics/800282/nichi-iko-pharmaceutical-research-and-development-expenses/
Shared Research. "Annual Expenses on Research and Development (R&d) of Nichi-iko Pharmaceutical Co., Ltd. from Fiscal Year 2013 to 2022 (in Billion Japanese Yen)." Statista, Statista Inc., 6 Jun 2022, https://www.statista.com/statistics/800282/nichi-iko-pharmaceutical-research-and-development-expenses/
Shared Research, Annual expenses on research and development (R&D) of Nichi-Iko Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen) Statista, https://www.statista.com/statistics/800282/nichi-iko-pharmaceutical-research-and-development-expenses/ (last visited March 29, 2024)
Annual expenses on research and development (R&D) of Nichi-Iko Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen) [Graph], Shared Research, June 6, 2022. [Online]. Available: https://www.statista.com/statistics/800282/nichi-iko-pharmaceutical-research-and-development-expenses/